Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Epoprostenol
(D01337)		[1] Epoprostenol[2] Epoprostenol ,
Epoprostenol sodium (D01337) 💬 		[1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
2Epoprostenol FOR injection
(D01337)		[1] Epoprostenol[2] Epoprostenol ,
Epoprostenol sodium (D01337) 💬 		[1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
3Epoprostenol sodico
(D01337)		[1] Epoprostenol[2] Epoprostenol ,
Epoprostenol sodium (D01337) 💬 		[1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
4Epoprostenol sodium
(D01337)		[1] Epoprostenol[2] Epoprostenol ,
Epoprostenol sodium (D01337) 💬 		[1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
5Epoprostenol-actelion
(D01337)		[1] Epoprostenol[2] Epoprostenol ,
Epoprostenol sodium (D01337) 💬 		[1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
6NEW thermo stable formulation OF epoprostenol sodium
(D01337)		[1] Epoprostenol[2] Epoprostenol ,
Epoprostenol sodium (D01337) 💬 		[1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬